In pancreatic cancers, CDK14 has been revealed as a hub gene in the interaction network including the Wnt/β-catenin pathway and phosphoinositide 3-kinase/Akt signaling pathway, and its increased expression is associated with poorer overall patient survival (Yuan et al. 2019). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.